Company Profile
Ionis Pharmaceuticals, Inc. Stock Price, News & Catalysts
- Ticker:
- IONS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
56.53 USD (+2.00%)
Close
Last updated: August 12, 2026
12.1B USD
Market cap
Why the stock is moving
As of Aug 12, 2026, IONS closed up 2.00% at $56.53. No new same-company headline was identified in the current news window.
Company overview
Business overview
Ionis Pharmaceuticals is an antisense-RNA company with one of the deepest RNA-targeting pipelines in biotech.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, it sits in specialty biotechnology with global partnered reach.
Business Model Characteristics
The company combines commercial products, royalties, milestones, and a pipeline of partnered and internally developed RNA programs.
Position Within the Biotechnology Landscape
Ionis is a premier RNA-platform name, and its stock tends to react to clinical data, partnership economics, and label expansion.
Future catalysts
- Ionis’s catalysts are olezarsen commercialization, donidalorsen / neurology progress, and broader RNA-targeting pipeline validation. The next update will help show whether the company is moving from promise to a more de-risked stage of execution. Investors will care less about the label than about whether the platform can keep producing credible next steps.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Ionis Pharmaceuticals, Inc. (IONS)?
Ionis Pharmaceuticals, Inc. (IONS) most recently closed at 56.53 USD, a +2.00% move versus the previous session.
What is the market cap of Ionis Pharmaceuticals, Inc. (IONS)?
Ionis Pharmaceuticals, Inc. currently has a market capitalization of 12.1B USD on BioPharmSignal.
What does Ionis Pharmaceuticals, Inc. do?
Ionis Pharmaceuticals is an antisense-RNA company with one of the deepest RNA-targeting pipelines in biotech.
On which exchange is IONS stock listed?
Ionis Pharmaceuticals, Inc. (IONS) is associated with NASDAQ, United States, Biopharma.
What is Ionis?
Ionis’s catalysts are olezarsen commercialization, donidalorsen / neurology progress, and broader RNA-targeting pipeline validation.
Which conditions is Ionis Pharmaceuticals, Inc. targeting with Ionis?
Ionis Pharmaceuticals, Inc. is associated with neurology based on its company overview and current catalyst commentary.
How does Ionis Pharmaceuticals, Inc. describe recent progress with Ionis?
Ionis’s catalysts are olezarsen commercialization, donidalorsen / neurology progress, and broader RNA-targeting pipeline validation.
What is Pharmaceuticals?
Ionis Pharmaceuticals is an antisense-RNA company with one of the deepest RNA-targeting pipelines in biotech.